Etomidate Injection — FDA Drug Shortage

Current — Eugia US LLC

The FDA lists a drug shortage record for Etomidate Injection (injection) from Eugia US LLC with status Current. The shortage was first posted on Oct 5, 2022. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Eugia US LLC
Package NDC
55150-222-20
Dosage Form
Injection
Presentation
Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)
Initial Posting
Oct 5, 2022

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.